Adipocytes derived from different anatomical sites vary in the expression of adipocytokines and growth factor genes. Adipogenesis is tightly associated with angiogenesis, although the regional variation of angiogenic growth factor gene expression in adipose tissues remains unclear. In this experiment, we studied the fat depot-specific differences (subcutaneous, intramuscular, intermuscular, renal, and mesenteric) in the expression of angiogenic growth factor mRNA [vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), fibroblast growth factor-10 (FGF-10), hepatocyte growth factor (HGF), and leptin], as well as the relationship between angiogenic growth factor mRNA level and adipocyte size in bovine adipose tissues. Intermuscular, renal, and mesenteric adipose tissues expressed significantly higher VEGF, FGF-2, and leptin mRNA levels than did subcutaneous and intramuscular adipose tissues. Mesenteric adipose tissue also expressed higher FGF-10 mRNA levels than did subcutaneous and intramuscular adipose tissues. There was no significant difference in the expression of HGF mRNA among adipose tissue depots. A significant correlation existed between adipocyte size and VEGF, FGF-2, FGF-10, and leptin mRNA levels. These results indicate that fat depot-specific difference in angiogenic growth factor gene expression results from the difference in adipocyte size.
Adipose tissue growth occurs through adipocyte hyperplasia and hypertrophy [34] . Two classes of transcription factors, the CCAAT/ enhancer-binding protein (C/EBP) family and the peroxisome proliferator-activated receptor  (PPAR), play essential roles during adipocyte differentiation in humans and rodents [15, 37, 42] . Recently, we showed that fattening periods [43] , breed differences between Wagyu and Holstein [44] , and differences in dietary roughage levels [45] affect the expression patterns of the C/EBP family in bovine adipose tissues.
An extensive capillary network is present in adipose tissue [10] . In addition, adipose tissue depots are distinct from each other based on blood vessel morphology and capillary density [10, 17] . The capillary network supplies nutrients to adipocytes and allows the adipocytes to actively secrete adipocytokines, such as leptin [6, 16, 33] . In addition, previous studies have indicated that adipogenesis is angiogenesisdependent. First, adipocyte proliferation takes place within vasculated cell clusters [8, 30] . Second, the inhibition of angiogenesis significantly reduces adipose tissue weight [30, 38] . Third, angiogenic growth factors stimulate adipocyte differentiation [21, 40] . Finally, the adipocyte itself secretes many angiogenic growth factors as described below.
Vascular endothelial growth factor (VEGF) is a very potent angiogenic factor secreted by adipocytes [29] . Fibroblast growth factor-2 (FGF-2) and fibroblast growth factor-10 (FGF-10) are also potent inducers of angiogenesis secreted by adipocytes [13, 14, 26] . Hepatocyte growth fac-tor (HGF) is also secreted by adipocytes and stimulates angiogenesis [3, 39] . Leptin is a major adipocytokine which plays a crucial role in the regulation of appetite and energy metabolism [6, 16, 33] . Leptin also stimulates angiogenesis [2, 7, 41] . Therefore, leptin not only acts as an endocrine hormone, but it also acts as a paracrine angiogenic growth factor. These results indicate that angiogenic growth factors secreted by adipocytes promote angiogenesis and stimulate adipogenesis through autocrine/paracrine actions. These results also suggest that angiogenic growth factor expression may be influenced by the anatomical sites of adipose tissues. However, fat depot-specific expression of angiogenic growth factor genes from various anatomical sites remains unclear. The objective of the present study was to elucidate the regional differences in the expression of angiogenic growth factor mRNA (VEGF, FGF-2, FGF-10, HGF, and leptin) in bovine adipose tissues from various anatomical sites (subcutaneous, intramuscular, intermuscular, renal, and mesenteric).
MATERIALS AND METHODS
Animals: Nine Japanese Black (Wagyu) steers aged 30 months were used in this study. They received concentrate (73% total digestible nutrients and 12% crude protein) and orchard grass hay ad libitum from 10 months of age until they were slaughtered. Adipose tissue samples from five types of fat tissues (subcutaneous, intramuscular, intermuscular, renal and mesenteric) were collected at slaughter. The left side of the carcass was sectioned between the 3rd and 4th lumbar vertebrae. The subcutaneous and intermuscular adipose tissues surrounding the longissimus muscle and the intramuscular adipose tissue within the longissimus muscle were collected from the section. The mesenteric fat was sampled from the area surrounding the colon. The renal adipose tissue was sampled from the area surrounding the kidney. All adipose tissue samples were collected immediately after slaughter, frozen in liquid nitrogen, and stored at -80C. Before RNA extraction, the frozen adipose tissue was stabilized in RNA-later-ICE reagent (Ambion, Austin, TX, U.S.A.). All animals received humane care as outlined in the Guide for the Care and Use of Experimental Animals (National Institute of Livestock and Grassland Science).
RNA isolation and Real-time PCR: Total RNA was extracted from adipose tissue using the RiboPure kit (Ambion) according to the manufacturer's instructions. The first-strand cDNA was reverse-transcribed from 0.5 g total RNA using the ReverTra Ace qPCR RT kit (Toyobo, Osaka, Japan) according to the manufacturer's protocol. Real-time PCR was performed with a Mini Opticon (Bio-Rad, Munich, Germany) using SYBR Green Real-time PCR Master Mix-Plus (Toyobo) according to the manufacturer's instructions. The primers for bovine angiogenic growth factors were designed as previously described [12, 24, 27, 32, 36] . The primer sequences were as follows: VEGF, 5'-GAA CTT TCT GCT CTC TTG GG-3' (forward) and 5'-CTG GCT TTG GTG AGG TTT GA-3' (reverse) [24] ; FGF-2, 5'-ACC GGT CAA GGA AAT ACT CCA G-3' (forward) and 5'-CAG GTC CTG TTT TGG GTC CA-3' (reverse) [27] ; FGF-10, 5'-AAC TCC TCT TCT TCT TCC TC-3' (forward) and 5'-TTC ACA GCA ACA ACT CCG AT-3' (reverse) [24] ; HGF, 5'-CGC TAC GAA GTC TGT GAC ATT CC-3' (forward) and 5'-GAT CCA TGG GAC CTC GGT AA -3' (reverse) [32] ; Leptin, 5'-GGA GAA GGT CCC GGA GGT T-3' (forward) and 5'-GGA CCA GAC ATT GGC GAT CT-3' (reverse) [12] ; Ribosomal protein large P0 (RPLP0), 5'-CAA CCC TGA AGT GCT TGA CAT -3' (forward) and 5'-AGG CAG ATG GAT CAG CCA -3'(reverse) [36] . The reaction conditions were designed as follows: initial denaturation at 95C for 60 sec followed by 40 cycles at 95C for 15 sec, 55C for 15 sec, and 70C for 30 sec. SYBR green fluorescence was detected at the end of each cycle to monitor the amount of real-time PCR product formed during that cycle. The specificity of the PCR products was determined by melting curve analysis at the end of each run. Standard curve of each product followed the calculation of respective gene expressions. The expression levels of angiogenic growth factor mRNA was normalized by RPLP0 as an internal control [31] .
Adipocyte cellularity: The samples of adipose tissue (subcutaneous, intramuscular, intermuscular, renal and mesenteric) were fixed with osmium tetroxide according to the method of Robelin [35] . Slices of adipose tissue were rinsed in 0.154 M NaCl and then fixed with 50 mM collidine-HCl buffer (pH 7.4) containing 2% osmium tetroxide. The slices were left in the fixative for 96 hr at room temperature. After fixation, the samples were rinsed in 0.154 M NaCl for 24 hr at room temperature. The fixed adipocytes were then isolated in a urea solution as reported by Etherton et al. [11] .
Fixed adipose tissue samples were placed into 8 M urea in 0.154 M NaCl for 48 hr at room temperature. Fixed and urea-isolated adipocytes were separated into 0.01% Triton X-100 in a 0.154 M NaCl buffer (pH 10). The adipocyte diameter was measured using WinRoof software (Mitani Corporation, Fukui, Japan). Over 300 adipocytes for each sample were measured according to the method of Lavau et al. [23] .
Statistical analysis: All results of angiogenic growth factor expression levels among fat depots are presented as the means  SD. The mean values among fat depots were compared by one-way analysis of variance (ANOVA) with post hoc analysis using Fisher's protected least significant difference test. The correlation between adipocyte size and angiogenic growth factor mRNA level was also determined. All data were analyzed using the StatView Version 5 program (SAS Institute Inc., Cary, NC, U.S.A.). Values of P<0.05 were considered significant.
RESULTS

Expression of angiogenic growth factor mRNA:
The VEGF mRNA levels were significantly different among adipose tissue depots. Intermuscular, renal, and mesenteric adipose tissues expressed significantly higher VEGF mRNA levels than did subcutaneous and intramuscular adipose tissues (Fig. 1A) . The FGF-2 mRNA levels were also significantly different among adipose tissue sites. The intermuscular, renal, and mesenteric adipose tissues expressed significantly higher FGF-2 mRNA levels than did subcutaneous and intramuscular adipose tissues (Fig. 1B) . The mesenteric adipose tissue also expressed higher FGF-10 mRNA levels than did subcutaneous and intramuscular adipose tissues (Fig. 1C ). Unlike other angiogenic growth factors, there was no significant difference in the expression of HGF mRNA among adipose tissue depots (Fig. 1D ). The leptin mRNA levels were significantly different among adipose tissue depots, and intermuscular, renal, and mesenteric adipose tissues expressed significantly higher leptin mRNA levels than did subcutaneous and intramuscular adipose tissues ( Fig. 1E) .
Relationship between angiogenic growth factor mRNA expression and adipocyte size: Figure 2 shows the osmium tetroxide-fixed adipocytes from (A) subcutaneous, (B) intramuscular, (C) intermuscular, (D) renal, and (E) mesenteric adipose tissues. Adipocyte size increased significantly in the following order: intramuscular (117.7  1.3 m), subcutaneous (137.5  4.1 m), intermuscular (147.0  13.0 m), renal (174.5  4.1 m), and mesenteric (176.2  13.7 m) adipocytes (Fig. 2F ). There was a significant correlation between adipocyte size and VEGF (r=0.47, P<0.01, Fig.  3A ), FGF-2 (r=0.52, P<0.01, Fig. 3B ), FGF-10 (r=0.56, P<0.01, Fig. 3C ), and leptin (r=0.74, P<0.01, Fig. 3E ) mRNA levels. No significant correlation was found between adipocyte size and HGF mRNA level (r=0.14, Fig.  3D ).
DISCUSSION
In the present study, we showed that intermuscular, renal, and mesenteric adipose tissues expressed significantly higher VEGF mRNA levels than did subcutaneous and intramuscular adipose tissues. Miyazawa-Hoshimoto et al. [29] also indicated that mesenteric adipose tissue expressed higher VEGF mRNA levels than did subcutaneous adipose tissue in mice. These results suggest that the expressional potency of VEGF mRNA in mesenteric adipose tissue is higher than that in subcutaneous adipose tissue. In addition, our study is the first to show the expression of VEGF mRNA in intermuscular, renal and intramuscular adipose tissue. Our results indicate that expression of VEGF mRNA in intermuscular and renal adipose tissue is relatively high, and this property is similar to that of mesenteric adipose tissue. In this study, a relatively low expression level of VEGF mRNA was also found in intramuscular adipose tissue, and this property is similar to that of subcutaneous adipose tissue.
In the present study, we showed that mesenteric adipose tissue expressed significantly higher FGF-2 and FGF-10 mRNA levels than did subcutaneous adipose tissues. In contrast, Gabrielsson et al. [13] showed that the expression levels of FGF-2 and FGF-10 mRNA were similar between subcutaneous and omental adipose tissues in humans. Therefore, the possibility cannot be ruled out that the difference between the results of Gabrielsson et al. [13] and those of the current study could be, at least in part, due to the differences in mesenteric and omental anatomical sites. We also showed for the first time that the expression of FGFs mRNA in intramuscular, renal and intermuscular adipose tissue. Our results indicated that the expression pattern of FGFs mRNA in intramuscular, renal and intermuscular adipose tissue show the similar tendency as VEGF mRNA expression.
In the present study, we showed that mesenteric, renal, and intermuscular adipose tissues expressed significantly higher leptin mRNA levels than did subcutaneous and intramuscular adipose tissues. Interestingly, we found that mesenteric adipose tissue expressed higher leptin mRNA levels than did subcutaneous adipose tissue. In contrast, Higashiyama et al. [19] showed that subcutaneous adipose tissue expressed higher levels of leptin mRNA than did omental adipose tissues in Wagyu steers. Both mesenteric and omental adipose tissues are classified as visceral fats, although Yang et al. [47] showed that the expression of leptin mRNA in mesenteric adipose tissue was significantly higher than that of omental adipose tissue in humans. These results suggest that the expressional potency of leptin mRNA in mesenteric adipose tissue may be higher than that in omental adipose tissue. Next, we examined the relationship between angiogenic growth factor mRNA level and adipocyte size. In the present study, we showed that there were significant positive correlations between the expression of angiogenic growth factor mRNA (VEGF, FGF-2, FGF-10, and leptin) and adipocyte size. Yang et al. [46] indicated that a positive correlation existed between adipocyte size and leptin mRNA level in crossbred steers. These results indicate that fat depot-specific difference in angiogenic growth factor gene expression results from the difference in adipocyte size. Hypoxia is known to be a potent angiogenic inducer [1] . Hypoxia led to an upregulation of hypoxia-inducible factor (HIF), which moves into the nucleus where it binds to hypoxia response elements within target angiogenic growth factor genes and initiates their transcription [5, 9, 22] . Hypoxia also stimulates the expression of leptin and VEGF mRNA in differentiated 3T3-F442A adipocytes [25] . In the present study, we showed that the adipocyte size in inter- muscular, renal, and mesenteric adipocytes was significantly larger than that in subcutaneous and intramuscular adipocytes. Helmlinger et al. [18] showed that the diffusion limit of oxygen is about 100-170 m from the capillaries.
Hosogai et al. [20] also reported that hypertrophic adipocytes, which increased up to 140-180 m, ensured a lessthan-adequate oxygen supply and were affected by hypoxic stress within adipose tissue. Interestingly, we showed that the size of intermuscular, renal, and mesenteric adipocytes was over 140 m and that of subcutaneous and intramuscular adipocytes was under 140 m. These results indicate that the fat depot-specific differences in angiogenic growth factor expression may be affected by adipocyte size and that adipocyte hypertrophy may favor the presence of local hypoxic areas and stimulate the expression of angiogenic growth factor gene. Our present study is the first to show that there was no significant difference in the expression of HGF mRNA among adipose tissue depots. In addition, no significant correlation was found between adipocyte size and HGF mRNA level. One explanation for these results might be the presence of splicing variants of HGF [28] . Bell et al. [4] showed that there was no difference in the expression of HGF mRNA in subcutaneous adipocytes between lean and obese subjects. These results suggest that anatomical site and adipocyte size may not affect the expression of HGF mRNA.
In conclusion, we have shown that the anatomical sites of bovine adipose tissues affected the expression of VEGF, FGF-2, FGF-10, and leptin mRNA. We have also shown a significant correlation between adipocyte size and VEGF, FGF-2, FGF-10, and leptin mRNA levels. These results indicate that fat depot-specific difference in angiogenic growth factor gene expression results from the difference in adipocyte size. ACKNOWLEDGMENTS. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 21780249).
